We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
Werfen

Download Mobile App




Radiotherapy Advances Presented at Research Summit

By MedImaging staff writers
Posted on 16 Mar 2006
Varian Medical Systems (Palo Alto, CA, USA) gathered over 100 radiation oncology researchers for a Research Partnership Summit in early February 2006. More...
The two-and-a-half-day gathering, held in Charleston, SC, USA, brought together physicists, biologists, veterinarians, and physicians who are conducting Varian-funded research.

"These presentations incorporate data that is only days or weeks old. It's an amazing snapshot of where the technology is at this point in time, for people who are really pushing the envelope,” commented Frank Bova, Ph.D., professor of neurosurgery at the University of Florida (Gainesville, FL, USA), who moderated a session on stereotactic radiosurgery, a procedure that involves treating a malignancy or neurological malformation with a carefully targeted single dose of radiation.

Other presentations covered product strategies for dealing with tumor motion during treatment, including the use of respiratory gating and other 4D imaging procedures and software that track and compensate for tumor motion caused by breathing.

Paul Keall, Ph.D., associate professor of medical physics at Virginia Commonwealth University provided a look at technology in development that can locate and track a tumor and adjust the treatment beam in direct response to internal or skeletal motion. Such a "dynamic compensation” approach would enable treatments that respond to tumor motion in real time by shaping and reshaping the radiation beams--something that is not yet possible in a commercially-available radiotherapy system.

Researchers also presented on projects involving biosynergy, ways in which biologically active agents can be used to enhance the clinical effects of radiation. Scientists from a number of U.S. colleges also presented data on compounds that make tumor cells more responsive to radiation, substances that protect normal tissues from the effects of radiation, and biomarkers that can be used to generate functional images with detailed information about tumor metabolism.



Related Links:
Varian Medical Systems

Gold Member
STI Test
Vivalytic Sexually Transmitted Infection (STI) Array
Antipsychotic TDM Assays
Saladax Antipsychotic Assays
Open Stapler
PROXIMATE Linear Cutter
Absorbable Monofilament Mesh
Phasix Mesh
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Surgical Techniques

view channel
Image: The AI-based approach identifies lipid regions matched well with histopathology results (Photo courtesy of Hyeong Soo Nam/KAIST)

AI-Based OCT Image Analysis Identifies High-Risk Plaques in Coronary Arteries

Lipid-rich plaques inside coronary arteries are strongly associated with heart attacks and other major cardiac events. While optical coherence tomography (OCT) provides detailed images of vessel structure... Read more

Patient Care

view channel
Image: The revolutionary automatic IV-Line flushing device set for launch in the EU and US in 2026 (Photo courtesy of Droplet IV)

Revolutionary Automatic IV-Line Flushing Device to Enhance Infusion Care

More than 80% of in-hospital patients receive intravenous (IV) therapy. Every dose of IV medicine delivered in a small volume (<250 mL) infusion bag should be followed by subsequent flushing to ensure... Read more

Business

view channel
Image: Medtronic’s intent to acquire CathWorks follows a 2022 strategic partnership with a co-promotion agreement for the FFRangio System (Photo courtesy of CathWorks)

Medtronic to Acquire Coronary Artery Medtech Company CathWorks

Medtronic plc (Galway, Ireland) has announced that it will exercise its option to acquire CathWorks (Kfar Saba, Israel), a privately held medical device company, which aims to transform how coronary artery... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.